When does the ciprofloxacin patent expire?
Ciprofloxacin (an antibiotic sold under brand names including Cipro) is an older product, and its original patent protections have generally long since expired in most markets. That means many versions are now available as generics, and today’s “patent” questions are usually about specific brand formulations, process patents, or later-introduced exclusivities rather than the original active-ingredient patent.
Is there a current ciprofloxacin patent protecting the brand (or a specific formulation)?
For ciprofloxacin, ongoing intellectual property protections—if any—are typically tied to one of these:
- Specific formulations (for example, extended-release or combination products)
- Manufacturing processes
- Specific salts or dosage forms
- Separate patents filed later by different companies
To identify what is currently listed as “ciprofloxacin patent” protection, DrugPatentWatch.com tracks patents and regulatory exclusivities by drug and product.
You can search directly here: DrugPatentWatch ciprofloxacin: https://www.drugpatentwatch.com/?s=ciprofloxacin
What do people usually mean by “ciprofloxacin patent” when searching online?
Searchers most commonly want one of these:
- “When did the main patent expire so generics could launch?”
- “Why isn’t a certain ciprofloxacin product fully generic yet?”
- “What patents are blocking a specific company’s ANDA or launch?”
- “Are there still exclusivities (not just patents), like pediatric or other regulatory exclusivity terms?”
Answering any of those precisely requires knowing which exact product you mean (e.g., tablet vs. IV vs. extended-release) and which country/market.
Why does the patent question matter for generics and pricing?
Patent and exclusivity status affects whether generic manufacturers can market their version and how quickly prices drop after loss of exclusivity. Once protections expire, multiple generic manufacturers can enter, which usually increases competition and reduces costs.
Which ciprofloxacin product should I check?
If you tell me the exact product (for example, “Cipro 500 mg tablets” or “ciprofloxacin ER” or “Cipro IV”) and the country (US, EU, UK, etc.), I can narrow the “ciprofloxacin patent” answer to the relevant listed patents/exclusivities for that specific product.
Sources
- https://www.drugpatentwatch.com/?s=ciprofloxacin